Home » Topics » BioWorld Science

BioWorld Science
RSS

Takeda launches Azilect in Japan for Parkinson's disease

June 12, 2018

Aquinox initiates phase II study of rosiptor in chronic prostatitis/chronic pelvic pain syndrome

June 12, 2018

Retrotope begins compassionate use trials of RT-001

June 12, 2018

FDA clears Arcus' INDs for AB-928 and AB-122

June 12, 2018

Arcus Biosciences presents CD73 inhibitors

June 12, 2018

Merck & Co. patents DGAT2 inhibitors

June 12, 2018

NeuroRx completes phase IIb/III feasibility enrollment for NRX-101 in suicidal bipolar depression

June 12, 2018

First-in-human data on FDL-176 in healthy subjects presented

June 12, 2018

EMA grants PRIME designation for Themis' Chikungunya vaccine

June 12, 2018

Merck KGaA reports promising phase II data for tepotinib in advanced HCC

June 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...